Delbet-Dupas C, Devoize L, Mulliez A, Barthélémy I, Pham Dang N. Does anti-inflammatory drugs modify the severe odontogenic infection prognosis? A 10-year’s experience. Med Oral Patol Oral Cir Bucal. 2021 Jan 1;26 (1):e28-35.


1. Jundt JS, Gutta R. Characteristics and cost impact of severe odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:558-66.


2. Uluibau IC, Jaunay T, Goss AN. Severe odontogenic infections. Aust Dent J. 2005;50:S74-81.


3. Flynn TR, Shanti RM, Hayes C. Severe odontogenic infections, part 2: prospective outcomes study. J Oral Maxillofac Surg. 2006;64:1104-13.


4. Opitz D, Camerer C, Camerer DM, Raguse JD, Menneking H, Hoffmeister B, et al. Incidence and management of severe odontogenic infections-A retrospective analysis from 2004 to 2011. J Cranio-Maxillofac Surg. 2015;43:285-9.


5. Sainuddin S, Hague R, Howson K, Clark S. New admission scoring criteria for patients with odontogenic infections: a pilot study. Br J Oral Maxillofac Surg. 2017;55:86-89


6. Seppänen L, Lauhio A, Lindqvist C, Suuronen R, Rautemaa R. Analysis of systemic and local odontogenic infection complications requiring hospital care. J Infect. 2008;57:116-22.


7. Kaplan HB, Edelson HS, Korchak HM, Given WP, Abramson S, Weissmann G. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol. 1984;33:371-8.


8. Giagoudakis G, Markantonis SL. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen. Pharmacotherapy. 2005;25:18-25.


9. Mathieu D, Neviere R, Teillon C, Chagnon JL, Lebleu N, Wattel F. Cervical necrotizing fasciitis: clinical manifestations and management. Clin Infect Dis. 1995;21:51-6.


10. Solberg CO, Allred CD, Hill HR. Influence of phenylbutazone on leukocyte chemiluminescence and function. Acta Pathol Microbiol Scand. 1978;86C:165-71.


11. Brun-Buisson CJ, Saada M, Trunet P, Rapin M, Roujeau JC, Revuz J. Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs. Br Med J Clin Res Ed.1985;290:1786.

PMid:3924256 PMCid:PMC1415937

12. Aronoff DM, Bloch KC. Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine. 2003;82:225-35.


13. Eter EG, Khazzaka A, Mneimneh W, Karam-Sarkis D, Haddad A, Sarkis R. Does diclofenac increase the risk of cervical necrotizing fasciitis in a rat model?. Int J Exp Pathol. 2009;90:58-65.

PMid:19200252 PMCid:PMC2669610

14. Weng TC, Chen CC, Toh HS, Tang HJ. Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. J Microbiol Immunol Infect. 2011;44:418-23.


15. Bennani-Baïti AA, Benbouzid A, Essakalli-Hossyni L. Cervicofacial cellulitis: The impact of non-steroidal anti-inflammatory drugs. A study of 70 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132:181-4.


16. Bali RK, Sharma P, Gaba S, Kaur A, Ghanghas P. A review of complications of odontogenic infections. Natl J Maxillofac Surg. 2015;6:136-43.

PMid:27390486 PMCid:PMC4922222

17. French Health Products Safety Agency (Afssaps). Prescribing antibiotics in odontology and stomatology. Recommendations by the French Health Products Safety Agency. Fundam Clin Pharmacol. 2003;17:725-9.


18. Jundt JS, Gutta R. Characteristics and cost impact of severe odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:558-66.


19. Flynn TR, Shanti RM, Levi MH, Adamo AK, Kraut RA, Trieger N. Severe odontogenic infections, part 1: prospective report. J Oral Maxillofac Surg. 2006;64:1093-103.


20. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?. Clin Infect Dis. 1995;21:977-80.


21. Stevens DL, Bryant AE. Necrotizing Soft-Tissue Infections. N Engl J Med. 2017;377:2253-65.


22. Hamilton SM, Bayer CR, Stevens DL, Bryant AE. Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis. J Infect Dis. 2014;209:1429-35.

PMid:24218498 PMCid:PMC3982845